Cabinet to assess 20 drugs in 2016 under new rules
Ministers charged with making life or death calls
Twenty expensive new medicines are expected to go to cabinet for approval this year, the Department of Health has said.
Under a radically changed approval process, the government now has to approve expensive medicines before the Health Service Executive (HSE) will pay for them.
New drugs to treat cancer, high cholesterol and cystic fibrosis are at various stages of the assessment process at present. The cumulative cost of these medicines is about €300 million per...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Analysis: Variants and vaccines make projecting path of virus more complex
While the vaccine rollout should reduce the number of new Covid-19 cases, the increased transmissibility of the new variant mean progress in suppressing the virus has slowed
HSE’s latest private hospitals Covid deal estimated to cost €47 million a month
HSE considers ending surge capacity arrangements with private hospitals as number of Covid-19 hospitalisations falls
Key public health posts remain vacant
Frustrated doctors snub HSE jobs as talks over the long-promised consultant contract stall
Breakdown of HSE’s €1.6 billion war chest to fight Covid-19
The National Service Plan shows that €200m of the €1.6bn allocated to fighting the pandemic is to be spent on the rollout of vaccinations
